The invention relates to methods of diagnosis or prognosis of a tissue or organ susceptible of developing a fibrosis, such as a lung or skin fibrosis, comprising the step of determining the levels of expression of genes, e.g. PI16, encoding different molecular markers in a sample of a tissue or organ from a mammalian, wherein said genes show differential expression when compared with the expression in normal fibroblasts of said mammalian.